HIMS
Hims & Hers Health, Inc. Class A · NYSE
- Sector Health Services
- Industry Medical/Nursing Services
- Website forhims.com
- Employees(FY) 651
- ISIN US4330001060
Performance
-12.93%
1W
+11.35%
1M
+54.85%
3M
+5.69%
6M
+194.38%
YTD
+214.15%
1Y
Profile
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Technical Analysis of HIMS 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-19 16:03
Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls(Yahoo Finance Video)
- 2024-12-19 15:57
- 2024-12-19 10:20
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List(Investor's Business Daily)
- 2024-12-17 19:00
HIMS: Raising target price to $33.00(Argus Research)
- 2024-12-17 10:48
Tesla, crypto miners, Hims & Hers Health: Trending Tickers(Yahoo Finance Video)
- 2024-12-12 09:00
- 2024-12-11 20:00
- 2024-12-10 19:00
HIMS: Lowering target price to $32.00(Argus Research)
- 2024-12-05 05:02
- 2024-12-04 19:00
- 2024-12-03 19:00
HIMS: Raising target price to $34.00(Argus Research)
- 2024-12-03 12:58
- 2024-12-02 23:58
- 2024-11-26 19:00
HIMS: Raising target price to $32.00(Argus Research)
- 2024-11-25 16:14
Hims & Hers surges: Analysts say it's well-positioned under Trump(Yahoo Finance Video)
- 2024-11-22 06:01
- 2024-11-21 12:00
- 2024-11-20 23:00
- 2024-11-20 14:44
Guardant Health Stock Sees RS Rating Jump To 83(Investor's Business Daily)
- 2024-11-18 06:00
- 2024-11-17 17:00
- 2024-11-17 03:53
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory(Insidermonkey)
- 2024-11-15 11:25
Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally(Investor's Business Daily)
- 2024-11-14 17:04
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments(The Wall Street Journal)
- 2024-11-14 10:27
Stock Market Today: Chevron Breaks Out, Disney Gets Some Of Its Mojo Back (Live Coverage)(Investor's Business Daily)
- 2024-11-13 09:48
- 2024-11-13 09:48
- 2024-11-13 09:15
- 2024-11-12 20:15
- 2024-11-12 19:00
HIMS: Raising target price to $28.00(Argus Research)
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.